S. Sharmokh

Budget Impact of 12-Month Fixed Treatment Duration Venetoclax in Combination with Obinutuzumab in Previously Untreated Chronic Lymphocytic Leukemia Patients in the United States

S. Shapouri, H. Parise, M. Davids, 2020, PharmacoEconomics.